Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient

There is no established chemotherapy regimen in metastatic primary urethral cancer (mPUC). The efficacy of a cisplatin (CDDP)-based regimen has been reported, however, when the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) occurs, the chemotherapy regimen should be changed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Yosuke, Naiki, Taku, Kondo, Masahiro, Iida, Keitaro, Kondo, Yuki, Tasaki, Yoshihiko, Kataoka, Tomoya, Hotta, Asami, Yasui, Takahiro, Kimura, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333508/
https://www.ncbi.nlm.nih.gov/pubmed/28271051
http://dx.doi.org/10.1016/j.eucr.2017.02.001
Descripción
Sumario:There is no established chemotherapy regimen in metastatic primary urethral cancer (mPUC). The efficacy of a cisplatin (CDDP)-based regimen has been reported, however, when the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) occurs, the chemotherapy regimen should be changed to another platinum compound. In this report, we describe a 66-year-old woman who was diagnosed as mPUC with, CDDP-induced SIADH. After switching her to CBDCA and careful managing her sodium balance, three courses of the chemotherapy regimen were completed.

Ejemplares similares